Despite advances in wound closure techniques and devices, there is still a critical need for new methods of enhancing the healing process to achieve optimal outcomes. Recently, stem cell therapy has emerged as a new approach to accelerate wound healing. Adipose-derived stem cells (ASCs) hold great promise for wound healing, because they are multipotential stem cells capable of differentiation into various cell lineages and secretion of angiogenic growth factors. The aim of this study was to evaluate the benefit of ASCs on wound healing and then investigate the probable mechanisms. ASCs characterized by flow cytometry were successfully isolated and cultured. An excisional wound healing model in rat was used to determine the effects of locally administered ASCs. The gross and histological results showed that ASCs significantly accelerated wound closure in normal and diabetic rat, including increased epithelialization and granulation tissue deposition. Furthermore, we applied GFP-labeled ASCs on wounds to determine whether ASCs could differentiate along multiple lineages of tissue regeneration in the specific microenvironment. Immunofluorescent analysis indicated that GFP-expressing ASCs were costained with pan-cytokeratin and CD31, respectively, indicating spontaneous site-specific differentiation into epithelial and endothelial lineages. These data suggest that ASCs not only contribute to cutaneous regeneration, but also participate in new vessels formation. Moreover, ASCs were found to secret angiogenic cytokines in vitro and in vivo, including VEGF, HGF, and FGF2, which increase neovascularization and enhance wound healing in injured tissues. In conclusion, our results demonstrate that ASC therapy could accelerate wound healing through differentiation and vasculogenesis and might represent a novel therapeutic approach in cutaneous wounds.
INTRODUCTION
attempted to promote chronic wound healing by increasing systemic or local levels of tissue growth factors, including transforming growth factor-β (TGF-β), fibro-Wound healing is a complex multifactorial process that involves the interaction of inflammation, reepitheli-blast growth factor (FGF), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF) (1,20,22, alization, angiogenesis, extracellular matrix (ECM) deposition, and remodeling (15, 33) . The process of wound 28, 31) . Modest satisfactory results in wound healing have been shown with various growth factors applica-healing is essential to prevent the invasion of damaged tissue by pathogens and to maintain the integrity of the tion. Nevertheless, technical difficulties in delivery and continuous release of growth factors, and enormous cost normal tissue (15) . However, healing of wounds is significantly compromised in a number of medical condi-limit the application of this therapeutic strategy. There is still a critical need for new methods of efficiently en-tions, such as diabetes and chronic renal failure. The mechanisms of compromised wound healing include hancing the healing process to achieve optimal outcomes. Recent studies have reported that stem cell therapy prolonged inflammation, decreased cellular infiltration and ECM formation, reduced growth factors, and im-may enhance wound healing. Adult stem cells have a prolonged self-renewal capacity with the ability to pro-paired neovascularization (6).
In the past decades, numerous strategies have been liferate and differentiate into various cell types. Fathke Phenotypes of ASCs were analyzed by fluorescencefibroblast population and accelerate wound healing (7) . activated cell sorting (FACS) (Becton-Dickinson, NJ, However, it is well known that the differentiation poten-USA). Passage 3 ASCs were resuspended in PBS contial of BMSCs significantly decreases as donor age intaining 2% fetal bovine serum at 10 6 cells per milliliter. creases (29) . Adipose-derived stem cells (ASCs) repre-These cell aliquots were incubated for 30 min on ice sent an attractive alternative of pluripotent cells with with fluorescein isothiocyanate (FITC)-or phycoerycharacteristics similar to BMSCs (10,11). Moreover, thrin (PE)-conjugated monoclonal antibodies: CD11compared with BMSCs, these cells have several advan-FITC, CD31-PE, CD44-FITC, CD45-PE, CD29-FITC, tages including ease of isolation, less donor morbidity, and CD90-PE. All antibodies were purchased from BD relative abundance, and rapidity of expansion (5, 11, 37) .
Pharmingen (San Diego, CA, USA). Isotype-matched Based on these outstanding features, ASCs have been normal IgGs were used as controls and data analysis was applied as a fascinating cell source for cell transplantaperformed with Cell Quest software. tion therapy in regenerative medicine (9, 26, 27, 32) . Pre-In Vitro Multilineage Differentiation of ASCs viously, we have proposed that ASCs could accelerate cutaneous wound healing (19) . Nevertheless, the precise
The culture-expanded ASCs were tested for their mechanisms that ASCs perform their contribution to ability to differentiate into adipocytes and osteoblasts. wound healing have not been clearly addressed.
Passage 3 ASCs were incubated in corresponding induc-In the present study, we implanted ASCs into excition medium for 3 weeks. In briefly, adipogenic differsional wounds in normal and diabetic rat, respectively, entiation was induced with isobutyl-methylxanthine (0.5 and examined their effects on wound healing compared mM), dexamethasone (1 mM), insulin (10 mM), and inwith vehicle control medium or fibroblasts. We hypothdomethacine (100 mM) in DMEM containing 10% FBS. esized that transplantation of ASCs might have the Then the cells were fixed in 10% formalin and stained ability to in situ differentiate into various lineages unwith Oil red O solution to show lipid droplets (Sigmader wound environment, including endothelial and epi-Aldrich). For osteogenic differentiation, cells were thelial cell, and produce various angiogenic cytokines induced in osteogenic induction medium of DMEM conthat stimulate angiogenesis. To the end, we tested this taining 10% FBS, dexamethasone (0.1 mM), ascorbatehypothesis and provided evidences that ASCs could ac-2-phosphate (0.2 mM), and β-glycerophosphate (10 celerate wound healing through differentiation and vas-mM). Osteogenic differentiation was confirmed by alkaculogenesis.
line phosphatase activity detection (Sigma).
Green Fluorescent Protein (GFP) Transfection MATERIALS AND METHODS of ASCs Isolation and Culture of ASCs
Preparation of cell infection and lentiviral superna-Adult male Lewis rats, average weight of 200-250 tants was performed as described previously (24, 36) . g, were provided by the Vital River laboratory animal Briefly, lentiviral vectors were produced by transient cocompany (Beijing, China) and used for the preparation transfection of HEK293T cells with three plasmids (Inof implanted ASCs. All animals received humane care vitrogen). The vector-containing supernatants were harin compliance with The Guide for the Care and Use of vested 48 h after transfection, filtered, and then stored Laboratory Animals. The following experimental protoat −80°C. To transduce ASCs with lentivirus constructs, col was approved by the ethical committee of Harbin cells were seeded at a density of 2 × 10 4 cells/cm 2 in six-Medical University. Animals were anesthetized using inwell plates. Various volumes (50-400 µl) of CMVtraperitoneal injection of 10% chloral hydrate (350 mg/ eGFP lentivirus suspension and 8 µg/ml polybrene kg). Inguinal rat fat pads were excised and washed ex-(Sigma-Aldrich) were added to EBM-2 (Cambrex) with tensively with PBS. They were minced finely and di-5% FBS in a total volume of 1 ml. Cells were allowed gested with 0.075% type I collagenase (Sigma-Aldrich) to incubate at 37°C for 12 h and replacing it with 2 ml in a 37°C shaking water bath for 1 h. The cell suspenfresh growth medium. At 3 days after transfection, GFPsion was centrifuged at 1200 rpm for 10 min and the positive cells were analyzed and sorted using FACS cell pellet was resuspended in growth media. Then, the Vantage SE cell sorter. cells were plated onto 100-mm 2 tissue culture plates and Preparation of Wound Healing Model maintained at 37°C in 5% carbon dioxide. Growth meand ASCs Transplantation dia was changed 24 h after the initial plating and every 3 days thereafter. ASCs were harvested at 90% conflu-Normal Lewis rats (n = 36) and diabetic rats (n = 36) were used in the model of wound healing. For prepara-ence and passaged into 1:3. tion of the diabetic wound model, the male rats were normal goat serum/0.3% Triton X-100/0.1% BSA (Sigma Aldrich) in PBS for 20 min at room temperature. The injected with a single dose of streptozotocin (STZ: 65 mg/kg) in 0.1 M citrate buffer (pH 4.5) after overnight sections were then incubated for 12 h at 4°C with the following primary antibodies (mAb): goat anti-GFP fasting to induce diabetes. Animals showing a blood glucose level nearly threefold higher compared with the (FITC, 1:100, ab6662, Abcam, USA), mouse anti-CD31
(1:100, sc-53526, Santa Cruz), or mouse anti-pan-cytok-control value were considered diabetic. At 2 weeks, normal and diabetic rats were anesthetized and prepared ac-eratin (1:100, sc-58826, Santa Cruz). Subsequently, the sections were rinsed with PBS and incubated with goat cording to standard sterile procedure. An 8-mm punch biopsy tool was used to create two circular, full-thick-anti-mouse IgG-TR (Texas Red) secondary antibody (1: 200, sc-2781, Santa Cruz) for 1 h at 37°C. Hoechst ness cutaneous wounds. A donut-shaped silicone splint was centered on the wound to prevent the wound con-33342 dye (C1026, Beyotime Institute of Biotechnology, Shanghai, China) was used to stain nuclei for 2 traction (8). After the preparation of wound healing model, normal rats and diabetic rats were randomly di-min. Finally, sections were examined and photographed with a fluorescence microscope. vided into three groups, including the sham group, ASCs group, and fibroblasts group. A total of 1 × 10 6 cells in Vessel Density Assessment 0.8 ml of PBS was injected intradermally around the wound at eight injection sites in the ASC and fibroblast For microvessel density determination, frozen sections were analyzed using mouse anti-CD31 primary an-groups. Animals in the sham group received 0.8 ml of PBS as control.
tibody (Santa Cruz). Goat anti-mouse IgG-TR was used as secondary antibody. The procedure was performed as Gross Wound Measurements the previously described. To the end, skin sections were digitized to an image and the number of CD31-positive Digital photographs were taken on the day of surgery and every other day thereafter. Time to wound closure vessels was quantified using Sigma Scan software across five nonconsecutive tissue sections for each wound. was defined as the time at which the wound bed was completely reepithelialized and filled with new tissue.
Enzyme-Linked Immunosorbent Assay (ELISA) The wound area was measured by tracing the wound of Growth Factors margin and calculating pixel area using Sigma Scan Pro Image analysis software. The percentage of wound clo-Growth factor levels for vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and fi-sure was calculated as follows: (area of original wound − area of actual wound)/area of original wound × 100%.
broblast growth factor 2 (FGF2) were determined using ELISA in vitro. Basal DMEM devoid of growth factors A wound was considered completely closed when the wound area was grossly equal to zero.
was added (10 ml) into 100-mm 2 culture plates seeded with 1 × 10 6 ASCs, and the supernatant was collected Histological Analysis of Wounds at 24, 48, and 72 h, respectively. The VEGF level was determined with quantitative ELISA Kit according to the Rats were sacrificed at 3, 7, 10, 14, and 28 days, at which times the wounds were excised, bisected, and manufacturer's instructions (RRV00, R&D Systems Inc). Rabbit anti-HGF antibody (ab83760, Abcam) and fixed in 10% formalin. Skin samples underwent routine histological processing with hematoxylin and eosin (H&E). rabbit anti-FGF2 antibody (sc-7911, Santa Cruz) were used as primary antibodies for ELISA. Goat anti-rabbit Digital analysis software was used to determine the epithelial gap (EG) and the total area of granulation tissue IgG-HRP (horseradish peroxidase) (ab6721, Abcam) was used to recognize the primary antibodies. After sub-(GT) from these photomicrographs. EG was defined as the distance between the advancing edges of keratino-strate solution of hydrogen peroxide (R&D Systems) was added into the plate, the optical density of each well cyte migration. An EG of zero represented a completely reepithelialized wound. Area of GT was calculated by was determined by spectrophotometer under the 450 nm wave length and the concentrations of growth factors tracing regions of GT and calculating the pixel area. The total area of granulation was defined as the sum of these were calculated. regions. Three samples were analyzed at each time point
Western Blot Analysis and the average was calculated to determine the amount of EG and GT present.
Western blot was used to measure the protein expression of VEGF, HGF, and FGF2 in skin samples in vivo.
Immunofluorescent Analysis
Skin tissue harvested from wounds was cut into smaller pieces and washed in sterile PBS. The tissue was centri-Skin biopsies were embedded with OCT and frozen in liquid nitrogen immediately for fluorescent immuno-fuged and resuspended into sample application buffer containing a protease inhibitor cocktail (Roche). Sam-staining. Frozen sections (6 µm) were blocked in 3% ples were boiled for 5 min and electrophoresed on 12% these cultured cells strongly expressed surface antigens such as CD29, CD44, and CD90. In contrast, no ex-polyacrylamide gel. Proteins were separated electrophoretically and transferred to nitrocellulose membranes pression of the hematopoietic and endothelial lineage markers (CD31 and CD45) was observed. They were (Bio-Rad). After blotting, the membranes were incubated with primary antibodies against VEGF (1:1000, also negative for the integrin CD11, an adhesion molecule characteristically found on leukocytes (Fig. 1A) . ab70612, Abcam), HGF (1:1000, ab83760, Abcam), FGF2 (1:500, sc-7911, Santa Cruz), and β-actin (1:1000,
The adherent cultured ASCs exhibited a fibroblast-like morphology (Fig. 1B) . Meanwhile, GFP + ASCs can be ab8227, Abcam) overnight at 4°C. Subsequently, they were incubated with HRP conjugated goat anti-Rabbit easily identified under a fluorescent microscope (Fig.  1C ). After cultured in adipogenic induction media for IgG antibody (1:3000, Abcam) for 1 h at room temperature. The immune complex was visualized by photo de-3 weeks, more than 90% of cells differentiated into adipocytes that could be stained with Oil red O ( Fig.  tection and quantified using scion image software.
1D, E). In addition, after osteogenic induction, more Statistical Analysis than 80% of cells differentiated into osteoblasts as Data are expressed as mean ± SD. Statistical compardemonstrated by alkaline phosphatase staining (Fig. isons between the groups were performed using either 1F, G).
Student's t-test or one-way analysis of variance (ANOVA)
Locally Administered ASCs Accelerate Wound Closure followed by Dunnett's test. A value of p < 0.05 was considered statistically significant.
In normal rat model of wound healing, time to complete wound closure was significantly shortened in the
RESULTS
ASCs-treated group. The average time for wound clo-Characterization of ASCs sure in the ASCs group was 11 ± 0.77 days whereas the time in the control group was 15 ± 0.63 days ( Fig. 2A) . To characterize the phenotypes of adherent ASCs, flow cytometry was performed. The results showed that In diabetic rat model, wounds treated with ASCs healed faster than those in control or fibroblasts group. Me-control and fibroblast-treated wounds (Fig. 3C) . These results indicated that ASCs significantly accelerated epi-dian time to closure for ASCs-treated wounds was 18 ± 0.41 days compared with 28 ± 0.58 days in the thelialization and granulation tissue deposition, and thus promoted wound healing. control group (Fig. 2B ). An increased rate of wound closure with ASCs treatment was more evident at post-Locally Administered ASCs Contribute to Epidermal operative day 7 and 10 in normal rat model (Fig. 2C) .
Structure and Enhance Wound Epithelialization At day 15, normal wounds in all groups were nearly healed. Compared with the control group, ASC therapy
To determine whether locally administered ASCs were incorporated into healing wounds, GFP + cells were revealed evident acceleration of healing at day 3, 7, 14, and 21 in diabetic rats. There was no difference for identified using fluorescent microscopy throughout the various substrata of the epidermis. We found a large time to closure between control and fibroblasts groups (Fig. 2D ).
number of GFP + cells were present at different location in ASCs-treated wounds, which might indicate multilin-The histological observation showed that tissue regeneration was much greater in the ASCs group com-eage differentiation potential of ASCs in vivo. Because of the GFP + cells partially found in the newly formed pared with control or fibroblasts group (Fig. 3A) . The experimental data also indicated ASCs treatment en-dermis and epidermis, wound sections were further costained for the epithelial marker cytokeratin and GFP to hanced epithelialization at all time points (Fig. 3B ). In addition, the amount of granulation tissue in ASCs-investigate whether ASCs have epithelial differentiation potential. At 7 days postoperative, engrafted GFP + cells treated wounds appeared to be more abundant. Poorly formed granulation tissue was significantly delayed in were seen incorporating into dermal structures in ASC- treated wounds and expressing positive signals for pan-Locally Administered ASCs Differentiate Into Vascular Structure cytokeratin. No GFP + cells were found in control or fibroblast groups, indicating specificity of the GFP immunostaining (Fig. 4) . These findings indicated that
To determine whether ASCs were engrafted into vascular structure, the GFP + cells were further examined for GFP + ASCs were incorporated into regenerated epidermal structures and enhance wound epithelialization.
concomitant staining CD31. GFP + cells were not de-tected in control and fibroblast groups. At postoperative cess, we examined the levels of growth factors in vitro and in vivo. ELISA showed that significantly higher lev-day 7, GFP and CD31 double-positive cells were found in newly formed capillaries, indicating spontaneous dif-els of VEGF and HGF were secreted by ASCs after 72h culture than that after 24-h culture (Fig. 7A, B ). FGF2 ferentiation of engrafted ASCs into a vascular endothelial phenotype (Fig. 5) . At postoperative day 14, in-in supernatant was always maintained at a low level (Fig. 7C) . Moreover, in vivo expression of VEGF, HGF, creased numbers of ASCs positive for GFP and CD31 appeared in vascular structures that seemed more ma-and FGF2 protein in wound samples was demonstrated by Western blot. The data revealed that strong VEGF ture. In addition, immunofluorescent analysis for CD31 demonstrated that ASCs therapy significantly increased and HGF protein expressions were observed in ASCtreated wounds, while they were lowly expressed in the neovascularization of wounds. Compared with the control group, blood vessel density was evidently increased control and fibroblast-treated wounds (Fig. 7D, E) . In addition, a slight but statistically significant enhance-in the ASC-treated group at postoperative day 7 ( Fig.  6A) . At day 14, mean vessel density in the ASC group ment in FGF2 protein expression was detected in ASCtreated wounds (Fig. 7F ). There was no significant dif-was 59.4 ± 2.13 vessels, whereas density in control group was 29.8 ± 1.64 vessels (Fig. 6B) . Our data sug-ference of protein levels between control and fibroblasts group. These results indicate that ASCs secrete angio-gest that ASCs could participate in the vasculogenesis process of wound healing through differentiate into vas-genic cytokines, notably HGF and VEGF, and strongly accelerate wound angiogenesis. cular endothelial cells.
ASCs Increase Angiogenic Factor Levels and Enhance DISCUSSION Wound Angiogenesis
Wound healing is a complex multifactorial process involving the interaction of inflammation, granulation To identify whether a correlation existed between particular growth factor levels and wound healing pro-tissue formation, reepithelialization, and angiogenesis Frozen sections of wound biopsies in each group were immunostained with an anti-CD31 antibody. Fluorescent micrographs showed that ASCs expressing GFP (green) were incorporated into vascular structures in ASC-treated wounds and expressing positive signals for CD31 (red). Nuclei were stained with Hoechst (blue). Green staining indicated the absence of GFP + cells in control and fibroblast groups. The merged images revealed that implanted GFP-labeled ASCs had differentiated into endothelial cells expressing CD31. Scale bar: 50 µm. (15, 33) . It has been shown that the healing of wounds model of excisional wound healing to determine the effects of ASCs, which prevents wound contraction and could be accelerated through delivery of BMSCs, providing strong evidence that MSCs have the extraordi-allows wounds to heal by epithelialization and granulation tissue formation (8). The gross observation showed nary plasticity and the ability to secrete growth factors that could promote tissue repair (34) . Similar to BMSCs, that ASCs significantly promoted wound healing process and reduced the time required for complete closure ASCs are other pluripotent cells that possess stem cell characteristics, such as extensive proliferation capacity, in both normal and diabetic rats. Furthermore, we found accelerated reepithelialization and increased granulation and differentiation potential (9,10,37). Moreover, ASCs have several outstanding features described previously tissue formation in the ASC group. Especially at day 7 and 10, treatment with ASCs had significant promotion (5, 11, 37) . Recently, it has been reported that ASCs could produce physiologically relevant levels of angio-effect on epithelial regeneration of wounds. Newly formed granulation tissues were found to be substan-genic and antiapoptotic growth factors (12, 13, 18, 23) . These reports make ASCs look more ideal and prompt tially thick and well developed in ASC-treated wounds. These findings suggested that the enhancement role of us to investigate the effects of these cells on wound healing.
ASCs on wound healing is associated with increased epithelialization and granulation tissue deposition. In this study, we have successfully isolated and cultured ASCs in vitro. Previous studies showed that ASCs
In an attempt to investigate the probable mechanisms by which ASCs enhance wound healing, we applied could be efficiently cryoperserved with different solutions, while maintaining their viability and differentia-GFP-expressing ASCs on wound healing to determine whether ASCs engrafted in the wound differentiate tion potential (21) . This would enlarge the range of application of ASCs in regenerative therapy. In addition, along multiple lineages of tissue regeneration in the specific microenvironment. It has been shown that under multilineage differentiation capacity of ASCs has also been confirmed and the result was consistent with previ-appropriate culture condition in vitro human ASCs have the potential of epithelial differentiation (2). Consistent ous reports (10,11). In in vivo study, we utilized a rat with this study, our results showed that GFP + ASCs in by ASCs was attributable to multiple differentiation in situ, including endothelial and epithelial lineages. How-vivo appeared to colocalize with stain against pan-cytokeratin, the first epithelial-specific structural proteins, in-ever, our data showed a rapid reduction of GFP + ASCs in wound at postoperative day 21 and thereafter. The dicating spontaneous differentiation into epithelial cells. Therefore, locally administered ASCs can accelerate underlying mechanisms may be related with progression of wound healing process. These observations further in-wound epithelialization through contributing to dermal keratinocytes.
dicated that in situ differentiation of ASCs was the response of multipotent ASCs to the wound microenviron-In addition, our data revealed that engrafted GFP + cells were observed to costain with CD31, an indicator ment, which is probably mediated by paracrine growth factors. of vascular endothelial phenotype. The observation provided further support that ASCs can in situ differentiate
The paramount importance of blood supply in the healing of wounds has been long appreciated. Recent into endothelial lineage and contribute to neovascular structures. This finding was consistent with previous research has highlighted the unique role of stem cells in revascularization following injury because of their mul-studies demonstrating hASCs could differentiate into endothelial cells and improve postnatal neovascularization tiple characteristics (3,30). In our study, increased capillary density after ASC injection around the wound bed (4). In a recent study, DiI-Labeled ASCs were also found enhancing the blood supply of skin flaps through was obvious with the naked eye, and this was proven by subsequent immunofluorescent analysis. In contrast, direct differentiation into endothelial cells (14) . Although we did not evaluate whether ASCs engrafted in treatment with fibroblasts had no significant effect on vessel density. The formation of new blood vessels is the wound might differentiate into a vascular smooth muscle phenotype, previous research had reported that necessary to sustain and enhance newly formed granulation tissue. Thus, increased capillaries might have di-ASCs possess the potential of myogenic differentiation in vitro (16) . In this study, we demonstrated that an im-rectly accounted for accelerated wound healing. There are at least two mechanisms involved in contribution of portant component of the wound healing effect induced
